Kiromic BioPharma, Inc.

General ticker "KRBP" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $46.3M (TTM average)

Kiromic BioPharma, Inc. does not follow the US Stock Market performance with the rate: -17.5%.

Estimated limits based on current volatility of 31.3%: low 0.06$, high 0.11$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.50$, 2.68$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.66$, 3.07$]

Financial Metrics affecting the KRBP estimates:

  • Negative: Non-GAAP EPS, $ of -3.50 <= 0.04
  • Negative: Operating cash flow per share per price, % of -43.21 <= 1.79
  • Negative: Shareholder equity ratio, % of -147.30 <= 22.52
  • Negative: negative Net income
  • Negative: negative Operating income
  • Negative: Industry earnings per price (median), % of -27.42 <= 0
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share, $ of 0.14 <= 0.67

Similar symbols

Short-term KRBP quotes

Long-term KRBP plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM
Operating Expenses $19.94MM $23.77MM
Operating Income $-19.94MM $-23.77MM
Non-Operating Income $-1.01MM $-3.12MM
Interest Expense $1.85MM $3.72MM
R&D Expense $6.95MM $6.85MM
Income(Loss) $-20.95MM $-26.90MM
Profit(Loss)* $-21.29MM $-26.90MM
Stockholders Equity $-9.12MM $-12.59MM
Assets $12.17MM $8.54MM
Operating Cash Flow $-21.23MM $-19.46MM
Capital expenditure $0.21MM $0.37MM
Investing Cash Flow $-0.21MM $-0.37MM
Financing Cash Flow $23.99MM $18.41MM
Earnings Per Share** $-0.65 $-1.03

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.